Laman UtamaAGIO • NASDAQ
add
Agios Pharmaceuticals Inc
$32.71
Selepas Waktu Dagangan:(0.00%)0.00
$32.71
Tutup: 25 Jun, 4:03:26 PTG GMT-4 · USD · NASDAQ · Penafian
Tutup sebelumnya
$33.42
Julat hari
$32.53 - $33.73
Julat tahun
$23.42 - $62.58
Permodalan pasaran
1.89B USD
Bilangan Purata
606.75K
Nisbah P/E
2.90
Hasil dividen
-
Pertukaran utama
NASDAQ
Berita pasaran
NVDA
4.33%
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(USD) | Mac 2025info | Perubahan T/T |
---|---|---|
Hasil | 8.73J | 6.56% |
Perbelanjaan pengendalian | 41.53J | 33.90% |
Pendapatan bersih | -89.29J | -9.49% |
Margin untung bersih | -1.02K | -2.75% |
Pendapatan bagi setiap syer | -1.55 | -6.90% |
EBITDA | -105.35J | -16.12% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
(USD) | Mac 2025info | Perubahan T/T |
---|---|---|
Pelaburan tunai dan jangka pendek | 893.38J | 49.40% |
Jumlah aset | 1.56B | 83.06% |
Jumlah liabiliti | 88.99J | -15.88% |
Jumlah ekuiti | 1.47B | — |
Syer tertunggak | 57.92J | — |
Harga kepada buku | 1.32 | — |
Pulangan pada aset | -16.56% | — |
Pulangan pada modal | -17.10% | — |
Aliran Tunai
Perubahan bersih dalam tunai
(USD) | Mac 2025info | Perubahan T/T |
---|---|---|
Pendapatan bersih | -89.29J | -9.49% |
Tunai daripada operasi | -111.49J | -11.64% |
Tunai daripada pelaburan | 112.59J | -9.61% |
Tunai daripada pembiayaan | 1.62J | -72.39% |
Perubahan bersih dalam tunai | 2.72J | -91.11% |
Aliran tunai bebas | -87.33J | -20.46% |
Perihal
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Diasaskan
2008
Tapak web
Pekerja
487